The current role of steroids in acute spinal cord injury (Q38085979)

28 August 2017

title

The current role of steroids in acute spinal cord injury (English)

1 reference

28 August 2017

Mohamad Bydon

1 reference

28 August 2017

Joseph Lin

1 reference

28 August 2017

Mohamed Macki

1 reference

28 August 2017

Ziya L Gokaslan

1 reference

28 August 2017

Ali Bydon

1 reference

28 August 2017

publication date

20 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

848-854

1 reference

Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methylprednisolone or vitamin E and selenium

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Anti-inflammatory actions of steroids: molecular mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Targeting the host inflammatory response in traumatic spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Predicting neurologic recovery in cervical spinal cord injury with postoperative MR imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Efficacy of Methylprednisolone in Acute Spinal Cord Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Acute enhancement of spinal cord synaptosomal (Na+ + K+)-ATPase activity in cats following intravenous methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Cervical spine injuries in children: a review of 103 patients treated consecutively at a level 1 pediatric trauma center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Incidence, characteristics, and outcome of spinal cord injury at trauma centers in North America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Multifactor clinical score and outcome of mechanical ventilation weaning trials: Burns Wean Assessment Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Acute inflammatory response in spinal cord following impact injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Predictors of hospital mortality and mechanical ventilation in patients with cervical spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

7 January 2021

Acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Cause of death for patients with spinal cord injuries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Epidemiology of spinal cord injury in children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Quality of life of individuals with spinal cord injury: a review of conceptualization, measurement, and research findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

High dose methylprednisolone in the immediate management of acute, blunt spinal cord injury: what is the current practice in emergency departments, spinal units, and neurosurgical units in the UK?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Acute effects of methylprednisolone sodium succinate on spinal reflexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

The role of steroids in acute spinal cord injury: an evidence-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Strategies of medical intervention in the management of acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Inflammatory-mediated injury and repair in the traumatically injured spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Effect of a single huge dose of methylprednisolone on blood flow, evoked potentials, and histology after acute spinal cord injury in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Incidence of traumatic spinal cord lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

End organ effects of high-dose human equivalent methylprednisolone in a spinal cord injury rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Pathophysiology and pharmacologic treatment of acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

The impact of methylprednisolone on lesion severity following spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Advances in secondary spinal cord injury: role of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Acute Treatment Options for Spinal Cord Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Histologic characterization of acute spinal cord injury treated with intravenous methylprednisolone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Methylprednisolone in acute spinal cord injury: a tarnished standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome--prospective study with 100 consecutive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Questionnaire survey of the views of the delegates at the European Cervical Spine Research Society meeting on the administration of methylprednisolone for acute traumatic spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Pharmacological therapy of spinal cord injury during the acute phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

An evaluation of the factors affecting neurological recovery following spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

High-dose methylprednisolone may do more harm for spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Efficacy of methylprednisolone therapy for the injured rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Urgent surgical decompression compared to methylprednisolone for the treatment of acute spinal cord injury: a randomized prospective study in beagle dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Calpeptin and methylprednisolone inhibit apoptosis in rat spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Methylprednisolone in acute spinal cord injury: is there any other ethical choice?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Epidemiology, demographics, and pathophysiology of acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Early complications of high-dose methylprednisolone in acute spinal cord injury patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Update on the pathophysiology and pathology of acute spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Changes in epidemiology of acute spinal cord injury from 1947 to 1981

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

Mortality following spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2013.02.062

10.1016/J.WNEU.2013.02.062

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference